eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web-based, On-premise, Cloud-based), Clinical Trial Phases, End User (CROs, Hospitals, Medical Device Manufactures) - Analysis & Forecast 2019-2030
Report ID : 33 | Published Date : Feb 2019 | Pages : 150 | Region : Global | Report Code : HIT-2
eClinical Solutions Market Overview and Introduction
The global eClinical Solutions Market is estimated to be over US$ 4.0 Bn in 2017.It is anticipated to grow at a CAGR of 13.0% from 2019 to 2030. eClinical Solutions are software and applications used for management of clinical trials and clinical research in pharmaceutical and biotechnology industry. The software helps to manage, maintain, record data, and track deadlines.
The global eClinical Solutions market is driven by increasing R&D expenditure in Pharmaceutical and Biotechnology companies, rising government funding and grants for clinical trials, growing adoption of eClinical Solutions to streamline R&D and clinical trial activity. However, high cost related to eClinical Solutions and lack of awareness & reluctance to adopt new technology is likely to restrain the market to certain extent. The global eClinical Solutions market is segmented by product, mode of delivery, clinical trials, end users and region. On the basis of Product, the eClinical Solutions market is segmented into Clinical Trial Management Systems (CTMS), Clinical Analytics Platform, Clinical Data Integration Platform, Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trail Master File (eTMF), Safety Solutions, and Other eClinical Solutions. The EDC and CDMS segment is estimated to account for the largest market share of the global eClinical Solutions market.
eClinical Solutions Market by Delivery Mode
Based on mode of delivery, the market is segmented into cloud based and on-premise & web based. The on-premise & web-based segment is estimated to account for the largest share of the global EClinical Solutions market. However, Cloud-based segment is attributed to grow at a faster growth rate. The faster growth rate can be attributed to increasing adoption of cloud based technology and reduced security threat to patient data on cloud based system.
eClinical Solutions Market by Clinical Trial Phases
On the basis of Clinical Trials, the market is segmented on Phase I, Phase II, Phase III, and Phase IV clinical trials. On the basis of application end users the market is segmented into Contract Research Organizations (CROs), Consulting Service Companies, Medical Device Manufacturers, Hospitals, and other end users.
eClinical Solutions Market by Regions
The global eClinical Solutions market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of eClinical Solutions, followed by Europe and Asia Pacific. North America will continue to dominate the global eClinical Solutions market in the forecast period owing to factors such as highly developed healthcare system and government initiatives to support clinical trials. However, Asia Pacific is expected to witness the highest growth rate, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries, and rise in outsourcing of clinical trials, are driving the growth of the eClinical Solutions market in this region. The high cost of eClinical Solutions products & setup and financial constraints of small and medium size organizations may restrain market growth to a certain extent.
eClinical Solutions Market Prominent Players
The prominent players in the global eClinical Solutions market are Oracle Corporation, EClinical Solutions, LLC, Parexel International Corporation, Bioclinica, Inc., Datatrak International Inc., ERT Clinical, Medidata solutions, Merger Healthcare Incorporated, Omnicomm Systems, Inc. and NextGen Healthcare